USFDA gives tentative approval to Alembic Pharma’s acalabrutinib capsules, 100 mg EP News Bureau Jan 19, 2023 The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product, calquence capsules, 100 mg, of…
